Clover Health is trading 4.23% lower at $4.53, with no clear company-specific catalyst identified for the decline. - The latest company release listed was October 8; its next quarterly results are scheduled for November 4. - The broader market is mixed: the Nasdaq is slightly higher, while the S&P 500 and Dow are lower.